Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet (ZBH) agreed to acquire the company for $13 in cash per share plus up $1 per share in a contingent value right.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.